Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

Market Cap	2.83B
Revenue (ttm)	973.86M
Net Income (ttm)	120.27M
Shares Out	105.15M
EPS (ttm)	1.15
PE Ratio	23.38
Forward PE	n/a
Dividend	0.22 (0.82%)
Ex-Dividend Date	Feb 17, 2025

Volume	1,587,499
Average Volume	2,689,050
Open	27.35
Previous Close	26.75
Day's Range	26.70 - 27.35
52-Week Range	22.30 - 34.02
Beta	-0.31
RSI	48.57
Earnings Date	Apr 25, 2025

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was founded in 1997 and is based in Xi'an, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 864
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002864

Financial Performance

In 2024, SHE:002864's revenue was 973.86 million, a decrease of -0.71% compared to the previous year's 980.83 million. Earnings were 120.27 million, an increase of 8.91%.